Home | About CDC | Press Room | A-Z Index | Contact Us
CDC Centers for Disease Control and Prevention Home Page
CDC en Español
Search:  


Division of Laboratory Sciences
National Report on Human Exposure to Environmental Chemicals

Environmental Phenols

Reference

Calafat AM, Wong LY, Ye X, Reidy JA, Needham LL. Concentrations of the Sunscreen Agent, Benzophenone-3, in Residents of the United States: National Health and Nutrition Examination Survey 2003-2004. Environ Health Perspect doi:10.1289/ehp. 11269 available at http://dx.doi.org/ [Online 21 March 2008]

Abstract

Background: The capability of benzophenone-3 (BP-3) to absorb and dissipate ultraviolet (UV) radiation facilitates its use as a sunscreen agent. BP-3 has other uses in many consumer products (e.g., as fragrance and flavor enhancer, photoinitiator, UV curing agent, polymerization inhibitor).

Objectives: To assess exposure to BP-3 in a representative sample of the U.S. general population aged 6 years and older.

Methods: We analyzed 2,517 urine samples collected as part of the 2003-2004 National Health and Nutrition Examination Survey using automated solid-phase extraction coupled to high-performance liquid chromatography-tandem mass spectrometry.

Results: We detected BP-3 in 96.8% of the samples. The geometric mean and 95th percentile concentrations were 22.9 µg/L (22.2 µg/g creatinine) and 1,040 µg/L (1,070 µg/g creatinine), respectively. Least square geometric mean (LSGM) concentrations were significantly higher (P≤0.04) for females than for males, regardless of age. LSGM concentrations were significantly higher for non-Hispanic whites than for non-Hispanic blacks (P≤0.01), regardless of age. Females were more likely than males (adjusted odds ratio [OR], 3.5; 95% confidence interval [CI], 1.9-6.5), and non-Hispanic whites were more likely than non-Hispanic blacks (adjusted OR, 6.8; 95% CI, 2.9-16.2) to have concentrations above the 95th percentile.

Conclusions: Exposure to BP-3 was prevalent in the general U.S. population during 2003-2004. Differences by sex and race/ethnicity probably reflect differences in use of personal care products containing BP-3.

Full Text

The full text of this publication is available from:
Environmental Health Perspectives (EHP)

Last Reviewed: April 3, 2008
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
Safer, Healthier People

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A.
Tel: 404-639-3311 • CDC Contact Center: 800-CDC-INFO • 888-232-6348 (TTY)
USA.govDHHS Department of Health
and Human Services